Age and Sex Specific Prevalence of Clinical and Screen-Detected Atrial Fibrillation in Hospitalized Patients
Authors:
- Laurent RotenLRLaurent Roten
- Eleni GouloutiEGEleni Goulouti
- Anna LamALAnna Lam
- Elena ElchinovaEEElena Elchinova
- Nikolas NozicaNNNikolas Nozica
- Alessandro SpiritoASAlessandro Spirito
- Severin WittmerSWSeverin Wittmer
- Mattia BrancaMBMattia Branca
- Helge ServatiusHSHelge Servatius
- Fabian NotiFNFabian Noti
- Jens SeilerJSJens Seiler
- Samuel H BaldingerSBSamuel H Baldinger
Open Access
- 22 October 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (21) , 4871
Abstract
Background: The prevalence of atrial fibrillation (AF) is high in older patients. The present study aimed to estimate the age and sex specific prevalence of clinical and screen-detected atrial fibrillation (AF) in hospitalized patients. Methods: The STAR-FIB cohort study was a prospective cohort study recruiting participants from a large source population of hospitalized patients aged 65–84 years. The estimated size of the source population was 26,035 (95% CI 25,918–26,152), and 795 consenting patients without clinical AF were included in the cohort study after stratification by sex and age (49.2% females; mean age 74.7 years). Patients in the cohort study underwent three seven-day Holter ECGs in intervals of two months to screen for AF. Results: In the source population, the estimated prevalence of clinical AF was 22.2% (95% CI 18.4–26.1), 23.8% for males (95% CI 20.9–26.6) and 19.8% for females (95% CI 17.3–22.4; p for difference between sexes, 0.004). There was a linear trend for an increase in the prevalence of clinical AF with increasing age, overall and in both sexes. In the cohort study, AF was newly diagnosed in 38 patients, for an estimated prevalence of screen-detected AF of 4.9% overall (95% CI 3.3–6.6), 5.5% in males (95% CI 3.2–7.8) and 4.0% in females (95% CI 2.0–6.0; p for difference between sexes, 0.041). The estimated prevalence of screen-detected AF in the source population was 3.8% overall, 4.2% in males and 3.2% in females. Conclusion: In a large hospital-based patient population aged 65–84 years, the prevalence of clinical AF and of screen-detected AF was 22.2% and 3.8%, respectively, and significantly higher in males than females.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (32003B_156292)
- Schweizerische Herzstiftung (N/A)
This publication has 25 references indexed in Scilit:
- Mass Screening for Untreated Atrial FibrillationCirculation, 2015
- Adverse prognosis of incidentally detected ambulatory atrial fibrillationThrombosis and Haemostasis, 2014
- Cryptogenic Stroke and Underlying Atrial FibrillationNew England Journal of Medicine, 2014
- The Clinical Profile and Pathophysiology of Atrial FibrillationCirculation Research, 2014
- Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmaciesThrombosis and Haemostasis, 2014
- A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: The Belgrade Atrial Fibrillation StudyInternational Journal of Cardiology, 2013
- Prevalencia de la fibrilación auricular y factores relacionados en pacientes ancianos hospitalizados: estudio ESFINGEMedicina Clinica, 2012
- Subclinical Atrial Fibrillation and the Risk of StrokeNew England Journal of Medicine, 2012
- Prevalence of Diagnosed Atrial Fibrillation in AdultsJAMA, 2001
- Population requirement for primary hip-replacement surgery: a cross-sectional studyThe Lancet, 1999